Anti-glaucoma compositions
AssigneeAlcon Laboratories, Inc.
InventorsLouis DeSantis, Jr., Rajni Jani
Life of this patent
Estimating the term…
Abstract
Ophthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and ocular hypertension are described. The compositions comprise a combination of a beta-blocker to reduce the production of aqueous humor and carbachol to enhance the outflow of aqueous humor. A method of controlling elevated intraocular pressure with those compositions is also described.
Claims6
A topical ophthalmic composition for the treatment of glaucoma and ocular hypertensions, comprising:
- about 0.25 wt% betaxolol;
- between about 1.5 and about 3.0 wt% carbachol;
- between about 0.05 and about 8.0 wt% of an anionic mucomimetic polymer;
- and about 0.05 and about 10.0 wt% of a finely divided cation exchange resin.
A method for treatment of glaucoma and ocular hypertension, comprising applying to an affected eye a composition comprising:
- about 0.25 wt% betaxolol;
- between about 1.5 and about 3.0 wt% carbachol;
- between about 0.05 and about 8.0 wt% of an anionic mucomimetic polymer;
- and between about 0.05 and about 10.0 wt% of a finely divided cation exchange resin.
Dependencies are inferred from the claim text.